Canadian Medical Center reported a net profit and Zakat and tax of SAR 5 million in the first six months of 2021, down 41% from SAR 8.4 million in the same period a year ago.
Item | 6m 2020 | 6m 2021 | Change |
---|---|---|---|
Revenues | 29.83 | 30.18 | 1.2 % |
Gross Income | 12.22 | 12.39 | 1.4 % |
Operating Income | 8.72 | 6.51 | (25.4 %) |
Net Income | 8.40 | 4.96 | (40.9 %) |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.11 | 0.06 | (40.9 %) |
The profit drop is attributed to one-off start-up costs for the new Saudi Aramco project which started operations on July 1, 2021, and listing costs in the parallel market, including costs for financial and legal advisors.
Item | H1 2020 | H1 2021 | Change |
---|---|---|---|
Revenues | 29.83 | 30.18 | 1.2 % |
Gross Income | 12.22 | 12.39 | 1.4 % |
Operating Income | 8.72 | 6.51 | (25.4 %) |
Net Income | 8.40 | 4.96 | (40.9 %) |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.11 | 0.06 | (40.9 %) |
Item | H2 2020 | H1 2021 | Change |
---|---|---|---|
Revenues | 34.38 | 30.18 | (12.2 %) |
Gross Income | 11.80 | 12.39 | 5.0 % |
Operating Income | 8.44 | 6.51 | (22.9 %) |
Net Income | 7.75 | 4.96 | (36.0 %) |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.10 | 0.06 | (36.0 %) |
Total revenues increased 1.18% to SAR 30.1 million in H1 2021 compared to SAR 29.8 million in the same period a year ago.
Total shareholders' equity stood at SAR 97 million in H1 2021 compared to SAR 14.5 million in the same period a year earlier, although there are no minority rights.
Net income and comprehensive income amounted to SAR 4.7 million in H1 2021 compared to SAR 8.5 million in the same period a year ago.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
H1 2012 | - | - | - | - | - | - |
H2 2012 | - | - | - | - | - | - |
2012 | - | - | - | - | - | - |
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | 53.56 | - | 21.29 | - | 16.30 | - |
H1 2020 | 29.83 | - | 12.22 | - | 8.72 | - |
H2 2020 | 34.38 | - | 11.80 | - | 8.44 | - |
2020 | 64.22 | 19.9 % | 24.03 | 12.9 % | 17.16 | 5.3 % |
H1 2021 | 30.18 | 1.2 % | 12.39 | 1.4 % | 6.51 | (25.4 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2011 | - | - | - | - | - | - |
2012 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | 53.56 | - | 21.29 | - | 16.30 | - |
2020 | 64.22 | 19.9 % | 24.03 | 12.9 % | 17.16 | 5.3 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
H1 2012 | - | - | - | - | - | - |
H2 2012 | - | - | - | - | - | - |
2012 | - | - | - | - | - | - |
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | 14.87 | - | 0.19 | - | 14.87 | 0.19 |
H1 2020 | 8.40 | - | 0.11 | - | 8.40 | 0.11 |
H2 2020 | 7.75 | - | 0.10 | - | 7.75 | 0.10 |
2020 | 16.15 | 8.6 % | 0.21 | - | 16.15 | 0.21 |
H1 2021 | 4.96 | (40.9 %) | 0.06 | - | 4.96 | 0.06 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2011 | - | - | - | - | - | - |
2012 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | 14.87 | - | 0.19 | - | 14.87 | 0.19 |
2020 | 16.15 | 8.6 % | 0.21 | - | 16.15 | 0.21 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2012 | - | - | - |
H2 2012 | - | - | - |
2012 | - | - | - |
H1 2013 | - | - | - |
H2 2013 | - | - | - |
2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
2019 | 39.75 % | 33.03 % | 27.77 % |
H1 2020 | - | - | - |
H2 2020 | 37.42 % | 31.13 % | 25.15 % |
2020 | 37.42 % | 31.13 % | 25.15 % |
H1 2021 | 37.48 % | 28.00 % | 19.70 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | 39.75 % | 33.03 % | 27.77 % |
2020 | 37.42 % | 31.13 % | 25.15 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2012 | - | - | - |
H2 2012 | - | - | - |
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | 40.97 % | 32.99 % | 28.15 % |
H2 2020 | 34.33 % | 29.52 % | 22.55 % |
H1 2021 | 41.06 % | 26.26 % | 16.44 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
H1 2012 | - | - | - | - |
H2 2012 | - | - | - | - |
H1 2013 | - | - | - | - |
H2 2013 | - | - | - | - |
H1 2014 | - | - | - | - |
H2 2014 | - | - | - | - |
H1 2015 | - | - | - | - |
H2 2015 | - | - | - | - |
H1 2016 | - | - | - | - |
H2 2016 | - | - | - | - |
H1 2017 | - | - | - | - |
H2 2017 | - | - | - | - |
H1 2018 | - | - | - | - |
H2 2018 | - | - | - | - |
H1 2019 | - | - | - | - |
H2 2019 | - | - | - | - |
H1 2020 | 77.00 | - | - | 0.19 |
H2 2020 | 77.00 | 0.21 | 0.21 | 1.20 |
H1 2021 | 77.00 | 0.17 | 0.17 | 1.26 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2011 | - | - | - | - |
2012 | - | - | - | - |
2013 | - | - | - | - |
2014 | - | - | - | - |
2015 | - | - | - | - |
2016 | - | - | - | - |
2017 | - | - | - | - |
2018 | - | - | - | - |
2019 | 77.00 | 0.19 | 0.19 | 0.15 |
2020 | 77.00 | 0.21 | 0.21 | 1.20 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
H1 2012 | - | - | - |
H2 2012 | - | - | - |
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021
2021
Period | Medical Clinics Sector | Medical Clinics Project Contracts Sector |
---|
Period | Medical Clinics Sector | Medical Clinics Project Contracts Sector |
---|---|---|
2020 | 2.02 | 62.20 |
Current | |
Market Cap (M Riyal) | 561.33 |
Enterprise Value (EV) (M) | 507.97 |
Shares Outstanding ((M)) | 77.00 |
Book Value (BV) ( Riyal) | 1.19 |
Par Value ( Riyal) | 1.00 |
Adjusted P/E (Last12) | 35.73 |
Price/book | 6.11 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}